Today: Rekordquartal für Apple, Ausblick enttäuscht | Evoniks gute Zahlen gegen Übernahme durch BASF
US-Tech-Gigant Apple und der Essener Chemiekonzern Evonik haben beide gute Quartalszahlen vorgelegt. Doch die allein reichen nicht: Während Apple die Anleger von der Zukunft überzeugen muss, kämpft Evonik um seine Eigenständigkeit.
Apple has achieved a record quarter, with revenue and profit exceeding expectations, but the outlook for the holiday period is less optimistic. In September's fourth quarter, Apple's revenue increased by 12% to $114.5 billion and earnings per share grew by 14% to $2.10. However, the growth outlook for the upcoming quarter is revised to a meager seven to ten percent, the weakest since over a year.
The stock price dropped three percent after hours following the announcement. Thomas Jahn, co-leader of the Technology team at Handelsblatt, provides further insight into Apple's situation and future. Meanwhile, the Essen-based chemical company Evonik reported strong fourth-quarter results on Tuesday. The adjusted operating profit rose by 40% to €629 million, while revenue grew by 13% to €3.8 billion.
Evonik's interim chief, Claus Rettig, emphasized the company's focus on its strategic direction and continued development as an independent entity during a conference call with analysts. The company's strong performance may be an attempt to deter a potential acquisition by its rival BASF. Evonik boosts operating profit and underscores independence.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
